• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童磷代谢紊乱,第 2 部分:低磷血症和高磷血症性疾病。

Disorders of phosphate homeostasis in children, part 2: hypophosphatemic and hyperphosphatemic disorders.

机构信息

Department of Medical Imaging, Ann & Robert H. Lurie Children's Hospital of Chicago, 225 E. Chicago Ave., Chicago, IL, 60611, USA.

Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Pediatr Radiol. 2022 Nov;52(12):2290-2305. doi: 10.1007/s00247-022-05373-z. Epub 2022 May 10.

DOI:10.1007/s00247-022-05373-z
PMID:35536416
Abstract

Phosphorus, predominantly in the form of inorganic phosphate PO, has many essential physiological functions. In the skeleton, phosphate and calcium form the mineral component and phosphate is also essential in regulating function of skeletal cells. Considerable advances have been made in our understanding of phosphate homeostasis since the recognition of fibroblast growth factor-23 (FGF23) as a bone-derived phosphaturic hormone. This second part of a two-part review of disorders of phosphate homeostasis in children covers hypophosphatemic and hyperphosphatemic disorders that are of interest to the pediatric radiologist, emphasizing, but not limited to, those related to abnormalities of FGF23 signaling.

摘要

磷主要以无机磷酸盐(PO )的形式存在,具有许多重要的生理功能。在骨骼中,磷与钙形成矿物质成分,磷对于调节骨骼细胞的功能也是必不可少的。自从发现成纤维细胞生长因子 23(FGF23)是一种骨源性排磷激素以来,人们对磷酸盐稳态的认识有了很大的提高。这篇儿童磷酸盐稳态紊乱的两部分综述的第二部分涵盖了低磷血症和高磷血症紊乱,这些紊乱与儿科放射科医师有关,强调但不限于与 FGF23 信号异常相关的紊乱。

相似文献

1
Disorders of phosphate homeostasis in children, part 2: hypophosphatemic and hyperphosphatemic disorders.儿童磷代谢紊乱,第 2 部分:低磷血症和高磷血症性疾病。
Pediatr Radiol. 2022 Nov;52(12):2290-2305. doi: 10.1007/s00247-022-05373-z. Epub 2022 May 10.
2
Disorders of phosphate homeostasis in children, part 1: primer on mineral ion homeostasis and the roles of phosphate in skeletal biology.儿童磷酸盐稳态紊乱,第 1 部分:矿物质离子稳态概论及磷酸盐在骨骼生物学中的作用。
Pediatr Radiol. 2022 Nov;52(12):2278-2289. doi: 10.1007/s00247-022-05374-y. Epub 2022 May 10.
3
Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.成纤维细胞生长因子23在调节全身磷酸盐稳态和细胞外基质矿化的骨-肾轴中的新作用。
Curr Opin Nephrol Hypertens. 2007 Jul;16(4):329-35. doi: 10.1097/MNH.0b013e3281ca6ffd.
4
Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.低磷血症性佝偻病:FGF23对磷稳态调控紊乱的启示
Curr Osteoporos Rep. 2015 Apr;13(2):88-97. doi: 10.1007/s11914-015-0259-y.
5
FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.成纤维细胞生长因子23(FGF23)、磷酸盐调节基因同源物(PHEX)和基质细胞外磷酸糖蛋白(MEPE)对磷稳态及骨骼矿化的调节
Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E1-9. doi: 10.1152/ajpendo.00016.2003.
6
Advances in understanding of phosphate homeostasis and related disorders.对磷酸盐稳态及其相关疾病的认识的进展。
Endocr J. 2022 Aug 29;69(8):881-896. doi: 10.1507/endocrj.EJ22-0239. Epub 2022 Jul 13.
7
[Fibroblast growth factor 23--a phosphate regulating hormone].[成纤维细胞生长因子23——一种调节磷酸盐的激素]
Ugeskr Laeger. 2010 May 17;172(20):1521-7.
8
Phosphate homeostasis disorders.磷酸盐平衡紊乱。
Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):685-706. doi: 10.1016/j.beem.2018.06.004. Epub 2018 Jun 18.
9
[Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism].成纤维细胞生长因子(FGF)23作为一种磷酸盐调节激素,参与多种磷酸盐代谢紊乱的发病机制。
Rinsho Byori. 2007 Jun;55(6):555-9.
10
[Epidemiology of FGF23-related hypophosophatemic diseases].[成纤维细胞生长因子23相关低磷性疾病的流行病学]
Clin Calcium. 2016 Feb;26(2):223-31.

引用本文的文献

1
Experts' consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan.关于X连锁低磷血症患者全生命周期管理与治疗的专家共识。
J Endocrinol Invest. 2025 Jul 1. doi: 10.1007/s40618-025-02611-7.
2
Diagnosis, treatment, and management of rickets: a position statement from the Bone and Mineral Metabolism Group of the Italian Society of Pediatric Endocrinology and Diabetology.佝偻病的诊断、治疗和管理:意大利儿科内分泌学和糖尿病学会骨与矿物质代谢组的立场声明。
Front Endocrinol (Lausanne). 2024 Apr 19;15:1383681. doi: 10.3389/fendo.2024.1383681. eCollection 2024.
3
Relationship between serum phosphate and mortality in critically ill children receiving continuous renal replacement therapy.

本文引用的文献

1
Ectopic Calcification and Hypophosphatemic Rickets: Natural History of ENPP1 and ABCC6 Deficiencies.异位钙化和低磷性佝偻病:ENPP1 和 ABCC6 缺乏症的自然病史。
J Bone Miner Res. 2021 Nov;36(11):2193-2202. doi: 10.1002/jbmr.4418. Epub 2021 Aug 16.
2
Autosomal recessive hypophosphatemic rickets type 2 (ARHR2) due to ENPP1-deficiency.常染色体隐性低血磷性佝偻病 2 型(ARHR2),系由于 ENPP1 缺乏所致。
Bone. 2021 Dec;153:116111. doi: 10.1016/j.bone.2021.116111. Epub 2021 Jul 9.
3
Correspondence on "Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI)" by Ferreira et al.
接受持续肾脏替代治疗的危重症儿童血清磷与死亡率之间的关系。
Front Pediatr. 2023 Apr 12;11:1129156. doi: 10.3389/fped.2023.1129156. eCollection 2023.
费雷拉等人关于“婴儿期全身性动脉钙化(GACI)长期幸存者的前瞻性表型分析”的通信
Genet Med. 2021 Oct;23(10):2006-2007. doi: 10.1038/s41436-021-01228-4. Epub 2021 Jun 14.
4
X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience.X 连锁低磷血症和布罗索尤单抗:来自法国经验的实用临床要点。
Joint Bone Spine. 2021 Oct;88(5):105208. doi: 10.1016/j.jbspin.2021.105208. Epub 2021 Jun 6.
5
Burosumab for Pediatric X-Linked Hypophosphatemia.布罗索尤单抗治疗儿童 X 连锁低磷血症。
Curr Osteoporos Rep. 2021 Jun;19(3):271-277. doi: 10.1007/s11914-021-00669-9. Epub 2021 May 10.
6
Switching from conventional therapy to burosumab injection has the potential to prevent nephrocalcinosis in patients with X-linked hypophosphatemic rickets.从传统治疗转换为布罗索尤单抗注射治疗有可能预防 X 连锁低磷血症性佝偻病患者的肾钙质沉着症。
J Pediatr Endocrinol Metab. 2021 Apr 12;34(6):791-798. doi: 10.1515/jpem-2020-0734. Print 2021 Jun 25.
7
FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment.成纤维细胞生长因子 23 相关低磷血症性佝偻病/骨软化症:诊断与新治疗。
J Mol Endocrinol. 2021 Feb;66(2):R57-R65. doi: 10.1530/JME-20-0089.
8
Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI).婴儿期全身动脉钙化(GACI)长期幸存者的前瞻性表型分析。
Genet Med. 2021 Feb;23(2):396-407. doi: 10.1038/s41436-020-00983-0. Epub 2020 Oct 2.
9
New Therapies for Hypophosphatemia-Related to FGF23 Excess.与 FGF23 过剩相关的低磷血症的新疗法。
Calcif Tissue Int. 2021 Jan;108(1):143-157. doi: 10.1007/s00223-020-00705-3. Epub 2020 Jun 5.
10
Tumor-Induced Osteomalacia.肿瘤相关性骨软化症。
Calcif Tissue Int. 2021 Jan;108(1):128-142. doi: 10.1007/s00223-020-00691-6. Epub 2020 Jun 5.